Dehaier Obtained Authorization From Olympus

Dehaier Obtained Authorization From Olympus

BEIJING, April 30, 2014 (GLOBE NEWSWIRE) -- Dehaier Medical Systems Ltd.
(Nasdaq:DHRM) ("Dehaier" or the "Company"), an emerging leader in the
development, assembly, marketing and sale of medical devices and sleep
respiratory products in China, today announced it has become the authorized
agent of Olympus (Beijing) Sales & Service Co., Ltd. ("Olympus") to supply its
electronic gastroscope and electronic bronchoscope products to participate in
several medical device procurement projects funded by the Chinese government.
Pursuant to the authorization letter with Olympus, Dehaier will be responsible
for bidding, agreement negotiation and execution of the projects.

Mr. Ping Chen, the Chairman and CEO of Dehaier, commented, "Dehaier is pleased
to serve as agent on behalf of Olympus to participate in several medical
equipment procurement bids. Olympus gastroscope and bronchoscope products are
popular in the industry and command a high market share. We are honored to be
recognized by Olympus, one of the world's top companies in the healthcare
sector. And we believe this relationship may benefit Dehaier in the short and
long term."

About Dehaier Medical Systems Ltd.

Dehaier is an emerging leader in the development, assembly, marketing and sale
of medical products, including medical devices and sleep respiratory products.
The company develops and assembles its self-branded medical devices and sleep
respiratory products from third-party components. The company also distributes
products designed and manufactured by other companies, including medical
devices from IMD (Italy), HEYER (Germany) and Timesco (UK). Dehaier's
technology is based on six patents and ten software copyrights. More
information may be found at http://www.dehaier.com.cn

Forward-looking Statements

This news release contains forward-looking statements as defined by the
Private Securities Litigation Reform Act of 1995. Forward-looking statements
include statements concerning plans, objectives, goals, strategies, future
events or performance, and underlying assumptions and other statements that
are other than statements of historical facts. These statements are subject to
uncertainties and risks including, but not limited to, product and service
demand and acceptance, fulfillment of bids and contracts, changes in
technology, economic conditions, the impact of competition and pricing,
government regulation, and other risks contained in reports filed by the
company with the Securities and Exchange Commission. All such forward-looking
statements, whether written or oral, and whether made by or on behalf of the
company, are expressly qualified by the cautionary statements and any other
cautionary statements which may accompany the forward-looking statements. In
addition, the company disclaims any obligation to update any forward-looking
statements to reflect events or circumstances after the date hereof.

CONTACT: Dehaier Medical Systems Limited
         +86 10-5166-0080
         Surie Liu lius@dehaier.com.cn
         Janice Wang wangxq@dehaier.com.cn
 
Press spacebar to pause and continue. Press esc to stop.